A delegation from the University Hospital, Sharjah, has concluded a visit to France. During the one-week visit, the delegation, comprising breast tumour consultants and specialists, held a series of meetings, workshops, and talks to exchange medical experience and discussed the latest developments in the field of breast cancer treatment.
The visit was made in pursuance of the agreement of cooperation signed between the University Hospital Sharjah and Friends of Cancer Patients (FoCP) and Gustave Roussy, one of the world’s leading cancer-research institutes and the biggest health centre dedicated to oncology in Europe, and in response to the directives of His Highness Dr Shaikh Sultan bin Mohammed Al Qasimi, Member of the Supreme Council and Ruler of Sharjah, within the framework of a cooperation agreement that Shaikh Sultan signed with the Gustave Roussy in 2010.
Intensive meetings and workshops were held between the UHS and specialists from Gustave Roussy during which latest developments pertaining to breast cancers and tumours were discussed. The discussions covered methods of treatment, early detection and microscopic diagnosis, as well as the role of awareness in the prevention of the disease.
Speaking on the occasion, Dr Hakam Yaseen, Medical Director at the University Hospital Sharjah, said: “In the light of the increasing number of breast cancer patients worldwide, we are committed to supporting the expertise of consultants and specialists in our hospital and providing them with the latest updates in this regard. This is part of our agreement with Gustave Roussy. We are proud of the unlimited support of His Highness the Ruler of Sharjah”.
“This generous support will help us to achieve even greater levels of excellence in patient treatment and develop the healthcare sector in the country, enabling it claim a leading position in the region,” Dr Yassen added.
The delegates conducted field visits to private clinics in France to discuss different breast cancer conditions with a multidisciplinary medical team. Various work plans were developed during the workshops, and parties agreed to exchange visits on a regular basis to stay abreast of the latest developments in detection and treatment, to follow up on patient treatment plans, and to evaluate patients’ conditions.
The latest developments in chemotherapy and radiotherapy methods were discussed during the meetings. The discussion also touched upon the latest in breast surgery and reconstruction as well as the latest treatment methods and medicines being administered to patients, and modern catheter techniques for intravenous chemotherapy were presented. The purpose of these techniques is to avoid any complications during chemotherapy period for breast cancer patients.